Incidence of HPV in women diagnosed with low-grade squamous intraepithelial lesion and atypical cells of undetermined significance on cytology
DOI:
https://doi.org/10.33448/rsd-v14i8.47971Keywords:
Cervical cancer, Epidemiology, Human papillomavirus (HPV), Real-time PCR, Pap smear.Abstract
The Human Papillomavirus (HPV) is the main risk factor associated with cervical cancer and its identification can help in the early diagnosis of malignant neoplasms. Therefore, the objective of the work is to identify the incidence of HPV genotypes in women with cytological results of low-grade squamous intraepithelial lesion and atypical cells of undetermined significance. The study is cross-sectional and retrospective, where the results of women who underwent the genotyping test for HPV and the cytopathological examination in a private laboratory in Aracaju/SE, between January and October 2022, were analyzed. Of the 7,915 women who performed vaginal secretion collection, 53.19% (75/141) were diagnosed with LSIL and 46.81% (66/141) with ASC-US. Of the detectable results for HPV, 68.42% (26/38) were diagnosed with high-risk HPV with genotypes other than 16 and/or 18. Therefore, a higher incidence of women diagnosed with LSIL was observed, in addition to the majority did not perform the genotyping test.
References
Abera, G. B. et al. (2023) Epidemiology of pre-cancerous cervical lesion and risk factors among adult women in Tigray, Ethiopia. PLoS ONE, 18(1), e0280191. doi: 10.1371/journal.pone.0280191.
Akakpo, P. K. et al. (2023). High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting. Infect Agents Cancer, 18(1). https://infectagentscancer.biomedcentral.com/articles/10.1186/s13027-023-00513-y.
Bessa, J. A. et al. (2023). Infecção cervical por papilomavírus humano em mulheres idosas. Revista Brasileira de Geriatria e Gerontologia. (26). https://doi.org/10.1590/1981-22562023026.230027.pt.
Cavalcante, G. L. et al. (2020) Cellular changes diagnosed by cérvico-vaginal cytology in a public health laboratory of Teresina-PI. Revista de Ciências Médicas e Biológicas, 19(1), 104.
Cardial, M. F. et al. Papilomavírus humano (HPV). In: Programa vacinal para mulheres. São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia, Cap. 4, p. 26-39. (Série Orientações e Recomendações Febrasgo; nº 13/ Comissão Nacional Especializada de Vacinas), 2017.
Ding, Y. Q. et al. (2023). Clinical and epidemiological features of high-risk human papillomavirus infection in patients with cervical intraepithelial lesions. BMC Women s Health. 1(23), 468. doi: 10.1186/s12905-023-02583-x.
Ferrera, L. et al. The association of Chlamydia trachomatis and human papillomavirus co-infection with abnormal cervical cytology among women in south of Morocco. Microbial Pathogenesis.175, 105971. doi: 10.1016/j.micpath.2023.105971.
Fredrich, É. K. & Renner, J. D. P. (2019). Cervical cytopathological changes in Pap smear test in the city of Santa Cruz do Sul, Rio Grande do Sul, Brazil. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2019 55(3). https://doi.org/10.5935/1676-2444.20190023.
Gonçalves, A. et al. (2024). Papilomavírus Humano (HPV) em Amostras Clínicas da População Brasileira. REVISTA CEREUS. 16(2), 240–53.
Husman, A.M. R. et al. (1995). The use of general primers GP5 and GP6 elongated at their 3’ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. The Journal of General Virology. 76(Pt 4): 1057-62. doi: 10.1099/0022-1317-76-4-1057.
INCA. (2022). Prevenção do câncer do colo do útero. Instituto Nacional do Câncer (INCA).
https://www.inca.gov.br/controle-do-cancer-do-colo-do-utero/acoes-de-controle/prevencao.
Júnior, S. F. L. et al. (2011). Prevalência dos genótipos do papilomavírus humano: comparação entre três métodos de detecção em pacientes de Pernambuco, Brasil. Revista Brasileira de Ginecologia e Obstetrícia. 10(33), 315–20.
Koliopoulos G. et al. (2017). Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database of Systematic Reviews. 8 (8).
Menêses, M. S. L. et al. (2023). Frequência do Papilomavírus Humano Oncogênico em Mulheres Atendidas no Centro de Oncologia da Bahia. Revista de Ciências Médicas e Biológicas, 22(4), 679–84.
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Editora da UAB/NTE/UFSM.
Pimple, S. & Mishra, G. (2022). Cancer cervix: Epidemiology and disease burden. Cytojournal. 19, 21.
Prado, P. R. et al. (2012). Caracterização do perfil das mulheres com resultado citológico ASCUS/AGC, LSIL e HSIL segundo fatores sociodemográficos, epidemiológicos e reprodutivos em Rio Branco-AC, Brasil. Revista Brasileira de Cancerologia. 58(3), 471-9.
Silva, M. L. et al. (2020). Conhecimento de mulheres sobre câncer de colo do útero: Uma revisão integrativa. Brazilian Journal of Health Review. 3 (4):7263–75.
Silva, A. E. et al. Frequência de lesões intraepiteliais e os principais microrganismos associados aos exames de Papanicolaou. Rev Bras Anal Clin. 55(1), 2023.
Stoll, L. F. et al. O exame citopatológico do colo uterino e sua obrigatoriedade nos concursos de admissão do Exército: aplicabilidade e validade. Revista Brasileira de Saúde Militar. 1(1):73–83, 2022.
Toassi, R. F. C. & Petry, P. C. (2021). Metodologia científica aplicada à área da Saúde. (2ed.). Editora da UFRGS.
Viñas-Sifontes, L. N. et al. (2020) Papiloma virus humano en adolescentes y jóvenes menores de 25 años. Revista Archivo Médico de Camagüey.24(3).
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Rafaela Windy Farias dos Santos, Odara Regina Menezes de Santana, Danielly Silva de Santana, Sinthia Regina dos Santos Lóz, Juçara Santos de Melo, Pâmela Silva Santos, Renata Cibelle Farias dos Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
